摘要
将体外循环心脏瓣膜置换术患者24例分为两组。对照组应用心肌冷停跳液灌注,试验组于冷停跳液中加入辅酶Q10(2mg/kg)。观察血浆MDA,红细胞SOD,血清CPK与CK—MB,心肌超微结构,临床表现。结果:(1)试验组氧自由基产生减少,酶学有降低趋势,心肌超微结构损伤较轻。(2)再灌注心律失常、术后室性心律失常与低心排发生人数较少。结论:冷停跳液加入辅酶Q10灌注对体外循环下心肌缺血再灌注损伤有一定保护性作用,应用于临床是可行的。
Twenty-four patients with valve replacement were randomly divided into two groups during extracorporeal circulation.Only cold crystalloid cardioplegia fluid was used in the control group.In coenzyme Q_10 group,coenzyme Q10 (zmg/kg) was added in the cold cardioplegia fluid.Plasma MDA、RBC、SOD、serum CPK and CKMB、myocardial ultrastructure and clinical data were observed.The results were:1) In coenzyme Q10 group,prcduction of oxygen free radical was decreased much significantly,the enzymes had the tendency to decline and the myocardial ultrastructure was better preserved;2) The incidence of reperfusedinduced arrhythmias,postoperative arrhythmias or low output syndrome after operations was lowes Lower in the enzyme Q10 group.The data suggested that using infusion with cold cardioplegia fluid including coenyme Q10 there was certain protective effect on myocardial ischemia reperfusion injury during cardiopulmonary bypass and this method was feasible clinicaly.
出处
《华西医学》
CAS
1997年第4期486-488,共3页
West China Medical Journal
关键词
辅酶Q10
酶
体外循环
心肌缺血
Coenzyme Q10
Cold crystalloid cardioplegia fluid
Enzyme
Myocardial Ultrastucture